Cup size predicts subsequent functional change in early glaucoma

Optometry and Vision Science

Volumn 88, Issue 12, 2011, Pages 1470-1476

  Gardiner, Stuart K ^a   Johnson, Chris A ^b   Demirel, Shaban ^a  

^a DEVERS EYE INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

confocal scanning laser ophthalmoscopy; glaucoma; perimetry; progression

Indexed keywords

CENTRAL CORNEAL THICKNESS; CONFOCAL SCANNING; FUNCTIONAL CHANGES; GLAUCOMA; INTRA OCULAR PRESSURE; LINEAR REGRESSION MODELS; MEAN DEVIATION; OCULAR HYPERTENSION; PERIMETRY; PROGRESSION; RATE OF CHANGE; RIM AREA; RISK FACTORS;

REGRESSION ANALYSIS;

OPHTHALMOLOGY;

ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMOSCOPY; OPTIC DISK; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; TIME;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMOSCOPY; OPTIC DISK; PROGNOSIS; TIME FACTORS;

EID: 82155162428     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3182303644     Document Type: Article

References (37)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7. (Pubitemid 43325451)
2. Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR. Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol 2010;128:276-87.
3. Broman AT, Quigley HA, West SK, Katz J, Munoz B, Bandeen-Roche K, Tielsch JM, Friedman DS, Crowston J, Taylor HR, Varma R, Leske MC, Bengtsson B, Heijl A, He M, Foster PJ. Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 2008;49: 66-76.
4. McKean-Cowdin R, Varma R, Wu J, Hays RD, Azen SP. Severity of visual field loss and health-related quality of life. Am J Ophthalmol 2007;143:1013-23. (Pubitemid 46764652)
5. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology 2008;115:941-8.
6. Anderson DR, Patella VM. Automated Static Perimetry, 2nd ed. St. Louis, MO: Mosby; 1999.
7. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56. (Pubitemid 36401765)
8. Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli J. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-35. (Pubitemid 39179673)
9. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, II, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20. (Pubitemid 34620349)
10. Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 2004;138: S19-31. (Pubitemid 39195354)
11. Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol 2007;125:1010-3. (Pubitemid 47258028)
12. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001;131:699-708. (Pubitemid 32522638)
13. Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007;114:205-9. (Pubitemid 46161799)
14. Johnson CA, Cioffi GA, Liebmann JR, Sample PA, Zangwill LM, Weinreb RN. The relationship between structural and functional alterations in glaucoma: a review. Semin Ophthalmol 2000;15: 221-33.
15. Keltner JL, Johnson CA, Anderson DR, Levine RA, Fan J, Cello KE, Quigley HA, Budenz DL, Parrish RK, Kass MA, Gordon MO. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology 2006;113:1603-12. (Pubitemid 44292332)
16. Gardiner SK, Demirel S. Assessment of patient opinions of different clinical tests used in the management of glaucoma. Ophthalmology 2008;115:2127-31.
17. Chauhan BC, McCormick TA, Nicolela MT, LeBlanc RP. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol 2001;119:1492-9. (Pubitemid 32963254)
18. Alencar LM, Zangwill LM, Weinreb RN, Bowd C, Sample PA, Girkin CA, Liebmann JM, Medeiros FA. A comparison of rates of change in neuroretinal rim area and retinal nerve fiber layer thickness in progressive glaucoma. Invest Ophthalmol Vis Sci 2010;51:3531-9.
19. Airaksinen PJ, Drance SM. Neuroretinal rim area and retinal nerve fiber layer in glaucoma. Arch Ophthalmol 1985;103:203-4. (Pubitemid 15173955)
20. Anton A, Yamagishi N, Zangwill L, Sample PA, Weinreb RN. Mapping structural to functional damage in glaucoma with standard automated perimetry and confocal scanning laser ophthalmoscopy. Am J Ophthalmol 1998;125:436-46. (Pubitemid 28236910)
21. Gardiner SK, Johnson CA, Cioffi GA. Evaluation of the structurefunction relationship in glaucoma. Invest Ophthalmol Vis Sci 2005; 46:3712-7.
22. Iester M, Mikelberg FS, Courtright P, Drance SM. Correlation between the visual field indices and Heidelberg retina tomograph parameters. J Glaucoma 1997;6:78-82. (Pubitemid 27183190)
23. Zangwill LM, Weinreb RN, Beiser JA, Berry CC, Cioffi GA, Coleman AL, Trick G, Liebmann JM, Brandt JD, Piltz-Seymour JR, Dirkes KA, Vega S, Kass MA, Gordon MO. Baseline topographic optic disc measurements are associated with the development of pri-mary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol 2005;123:1188-97. (Pubitemid 41316732)
24. Spry PG, Johnson CA, Mansberger SL, Cioffi GA. Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma 2005;14:11-9. (Pubitemid 40165486)
25. Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand 1997;75:368-75. (Pubitemid 27470462)
26. Fingeret M, Flanagan JG, Liebmann JM, eds. The Essential HRT Primer. San Ramon, CA: Jocoto Advertising, Inc; 2005.
27. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26:233-6.
28. Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bull 1980;87:245-51.
29. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol 2008;145:343-53.
30. Fortune B, Demirel S, Zhang X, Hood DC, Patterson E, Jamil A, Mansberger SL, Cioffi GA, Johnson CA. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci 2007;48:1173-80. (Pubitemid 351261412)
31. Bellezza AJ, Rintalan CJ, Thompson HW, Downs JC, Hart RT, Burgoyne CF. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci 2003;44:623-37. (Pubitemid 36159708)
32. Yang H, Downs JC, Girkin C, Sakata L, Bellezza A, Thompson H, Burgoyne CF. 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: lamina cribrosa and peripapillary scleral position and thickness. Invest Ophthalmol Vis Sci 2007;48: 4597-607. (Pubitemid 351260977)
33. Gardiner SK, Demirel S, Johnson CA. Perimetric indices as predictors of future glaucomatous functional change. Optom Vis Sci 2011; 88:56-62.
34. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-8. (Pubitemid 28171344)
35. Artes PH, Chauhan BC. Properties of the Statpac Visual Field Index (VFI). Invest Ophthalmol Vis Sci 2010;51:E-abstract 5494.
36. Artes PH, O'Leary N, Hutchison DM, Heckler L, Sharpe GP, Nicolela MT, Chauhan BC. Properties of the Statpac Visual Field Index. Invest Ophthalmol Vis Sci 2011;52:4030-8.
37. Doss LE, Mock D, Kwong A, Shaikh Y, Coleman AL, Nouri-Mahdavi K, Caprioli J. The Visual Field Index (VFI) behaves erratically near the advanced field loss mean deviation value. Invest Ophthalmol Vis Sci 2011;52:E-abstract 5495.